Comparison of postpartum blood loss between intravenous oxytocin and intravenous methylergometrine maleate during third stage of labor

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

TCTR

Registry ID

TCTR20120000012

Enrollment

Unknown

Registered

2012-08-06

Start date

2011-08-01

Completion date

Unknown

Last updated

2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Postpartum hemorrhage Postpartum hemorrhage Ergometrine Oxytocin Third stage of labor

Interventions

After baby birth the parturients who were allocated to the oxytocin group received additional oxytocin 20 units added into solution 500 – 1000 ml of 5% D/N/2 intravenous infused at rate of 60 ml/minut

Experimental Drug,Experimental Drug

Oxytocin,Ergometrine

Eligibility

Sex/Gender

Female

Age

18 Years to 34 Years

Inclusion criteria

Inclusion criteria: 1. Parturients who had normal vaginal delivery 2. Singleton pregnancy 3. Gestational age 37-41 weeks 4. Newborn birth weighed equal or greater than 2500 grams with Apgar score at 1, 5 minutes equal or greater than 7.

Exclusion criteria

Exclusion criteria: Parturients who had complications during pregnancy and were hypersensitive to oxytocin and/or ergometrine.

Design outcomes

Primary

Measure	Time frame
Postpartum blood loss 2 hours after baby birth Absorbable pad and blood collecting plastic bag	—

Secondary

Measure	Time frame
side effects and complications of delivery 2 hours after baby birth A parturient’s record form	—

Countries

Thailand

Contacts

Public ContactSirikanya Phaikaew

Department of Obstetrics and Gynecology, Faculty of Medicine Ramathibodi Hospital, Mahidol Universit

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 9, 2026